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Illicitly manufactured fentanyl
(IMF)
 Acetyl fentanyl, U-47700, carfentanil, etc. analogues
 50 to 1000s of times more potent than morphine
 Standard tests do not distinguish from
pharmaceutical fentanyl
 Legal status depends on the analogue
 Police avoidance of contact and local testing
 Counterfeit Rx drugs as well as powder

Timeline
 1981 first fentanyl analogue Schedule 1
 Fentanyl-laced heroin / fentanyl powder:
2012
British Columbia
April 2013 Maine
 Counterfeit Rx medications:
May 2013 Montreal
Sept 2013 Louisiana, Rhode Island
 2013-????
Escalating overdose deaths
 June 2016
Carfentanil seized: China->Calgary
 July 2016
Carfentanil ODs in Ohio

Timeline (continued)
Public health actions:
2010 Expansion of US Rx opioid controls
June 2013
CCENDU warns Rx and IMF
Dec 2014
Alberta IMF warning
March 2015 US DEA IMF warning
May 2015
US DEA: acetyl fentanyl Sched 1
Oct 2015
China controls fentanyl analogues
Oct 2015
CDC warning / clinical guidelines
April 2016
US DEA counterfeit pill warning
CDC opioid Rx guidelines
Sept 2016
US DEA carfentanil warning
March 2017 China controls carfentanil

Hypothesis
Systematic data collection from a national
sample of law enforcement agencies on
new cases of illicitly manufacture fentanyl
will provide timely information about the
scope and geographic concentration of the
IMF problem.

Data Sources
Law enforcement and public health
news reports were researched to
compile the history of IMF
distribution in Canada.
Data for the U.S. were compiled from
the Drug Diversion Program of the
RADARS® surveillance system from
1/1/2013 through 3/31/2017.

2012: New IMF Canadian Trafficking

2016
carfentanil

2012
CHINA

2014

Canada IMF Market
 High volume Chinese trade through
Vancouver
 No searches of parcels under 30 grams in
weight without cause
 Distant from Mexico heroin sources

Drug Diversion Program
 Number of new cases of pharmaceutical


diversion investigated by law enforcement
units or reported to state regulatory boards
250 reporters from 49 states

IMF:
- Open-ended responses to a question about
new drug trends
- 2Q2016 added to the survey as a target

3-Digit ZIP Codes Reporting to Drug
Diversion for 2016

2002-2015 Diversion Rates (per 100,000 pop)
No change in Rx fentanyl diversion

3Q2014 – 1Q2016
Reports of IMF in the write-in
section of the DD survey

3Q 2014

No reports of IMF
IMF powder alone or mixed
Alaska

Hawaii

IMF in counterfeit Rx tablets

1Q 2016 (cumulative)

No reports of IMF
IMF powder alone or mixed
Alaska

Hawaii

IMF in counterfeit Rx tablets

2Q1016 – 1Q2017
IMF Target Drug Survey
Responses

IMF in counterfeit Rx tablets

1-5 cases
6-15 cases
Alaska

Hawaii

>90 cases

IMF powder alone or mixed

1-5 cases
6-35 cases
Alaska

Hawaii

> 35 cases

IMF spray

1 case
Alaska

Hawaii

CDC High Burden States AUG 2016

Alaska

Hawaii

Reporter comments
“In the last quarter of 2015, we seized over 1 pound
of fentanyl destined for South Florida. It is
present in our area and is becoming a greater
problem all the time.” – Reporter in TN
“The most recent trend in heroin sales that it is
being laced with fentanyl and the street nickname
for it is “China White. I have also heard of a
fentanyl inhalant/spray that people have been
abusing. But have not arrested anyone for it yet.”
- Reporter in MD

Reporter comments
“We have also seen an influx of people producing
and manufacturing their own pills with presses at
their homes and businesses. Most of the heroin
and fentanyl are being formed and sold as
oxycodone but lab results are indicating
otherwise. There are some older molds for
oxycodone 30mg pills out there and maybe this is
why the dealers are disguising heroin as
oxycodone? More to come.” - Reporter in FL

1Q2017 Updated DD History Map

No reports of IMF
IMF powder alone or mixed
Alaska

Hawaii

IMF in counterfeit Rx tablets

Discussion
 Canada and US have different but
complementary drug trafficking routes
 Illicit drug trade adapts to Rx opioid misuse
trends and control measures
Most worrisome:

high potency illicit fentanyl analogues are
easily camouflaged and transported

mass produced counterfeit Rx products

Discussion
 The Drug Diversion Program detected the first
signal of IMF in Ohio in the 3Q 2014.
 By 1Q 2017, IMF reports had been received
from 30 states, primarily along the east and
west coasts and the Canadian border
 The systematic collection of these surveillance
data in the U.S. signaled the entry of IMF into
the US approximately six months before public
health notices.

IMF trafficking policy issues
 Ongoing systematic surveillance is needed,
including counterfeit Rx products
 Drug Diversion Program adds value:






Systematic quarterly data collection
Large sample of drug diversion investigators
Identification of product form
Timely reporting, early warning system
Includes qualitative data to describe the problem

 International cooperation needed for control
 Improvements in laboratory testing accuracy and
timeliness are needed

